Human Xtensions

Company Overview

Snapshot

Founded in January 2012, Human Xtensions operates with 11–50 employees and has raised a total of $66 million across three funding rounds from seven investors. The company went public on the TASE in December 2020.

Business overview

Human Xtensions is a medical robotics company that develops software-driven devices designed to enhance minimally invasive surgery. Its core product, HandX, is a lightweight, hand-held device that translates a surgeon’s natural hand motions into complex movements inside the patient, aiming to restore ease and comfort by providing proper ergonomic positioning and increased freedom, flexibility, proximity, and control. The company operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving the global healthcare market.

Strategic signal

In October 2023, Human Xtensions entered into a distribution agreement with a company in Abu Dhabi, signaling strategic expansion into new regional markets. This move indicates the company's efforts to broaden its commercial reach and capitalize on international opportunities for its surgical robotics technology.

Company Intelligence Q&A

When did Human Xtensions go public?

Human Xtensions went public on the TASE in December 2020.

What was a key product development for Human Xtensions?

In March 2018, Human Xtensions received FDA 510(k) clearance for HandX, its smart, electro-mechanically simplified surgical system designed to integrate all components for a modular platform.

What strategic partnership did Human Xtensions announce in 2023?

In October 2023, Human Xtensions entered into a distribution agreement with a company in Abu Dhabi.

What was a significant funding event for Human Xtensions?

In January 2019, Human Xtensions secured a funding round led by.

What operational change did Human Xtensions implement in April 2023?

In April 2023, Human Xtensions reduced its operations in the US, aiming to save 31% of its expenses.